BIOMEDevice Boston, the east coast's premier biomedical event for engineers, innovative thinkers, and business leaders, has opened registration for its 2021 event. Taking place September 21-22 at the Boston Convention & Exhibition Center as a live in-person experience, BIOMEDevice Boston will feature more than 200 industry-leading suppliers driving new technological breakthroughs and advancements. The event will also offer attendees access to free, world-class educational sessions and exert-led panel discussions focused on 3D printing, digital health, and surgical robotics. To attend the free event, visit here.

The biotechnology market is expected to reach $2.44 trillion by 2028. "Progress in healthcare is driven by two powerful forces: continued education that facilitates discovery and industry-wide collaboration. We are proud to offer both at this year's event, illuminating the companies and experts that are revolutionizing the biomedical field," said Hayley Haggarty, group event director, BIOMEDevice Boston, organized by Informa Markets Engineering, which is also the publisher of MD+DI.

New to the BIOMEDevice brand will be two Show Floor Zones dedicated to 3D Printing and Robotics. Each zone will serve as a networking hub for attendees to mingle and meet suppliers specializing in their respective zone.

First-rate supplier and expert-led panel discussions and presentations will unfold at the Tech Theater and Center Stage, with topics ranging from how to infuse next-gen technology into the medical field to inspiring the next life-changing medical device. All event experiences will be accessible to attendees on the interactive expo floor. 

Running adjacent to BIOMEDevice Boston at the Boston Convention & Exhibition Center from September 20-23 is Biotech Week Boston, a festival highlighting 11 biotech and pharma events accelerating the business of biotechnology through new ideas, science, technology, and partnerships to make a positive impact on patient health. This year's festival, organized by Informa Connect Life Sciences, features a curated series of general assembly keynotes from life science luminaries that will capture the attention of the entire festival. Among these renowned biopharma leaders includes Katalin Karikó, PhD, Senior VP RNA Protein Replacement Therapy at BioNTech; John Maraganore, PhD, CEO of Alnylam; Charles Sardonini, PhD, Head of Drug Substance Manufacturing at Sanofi; and Hao Chen, PhD, Head of Cell & Viral Drug Substance at GSK Vaccines, to name a few. To see a full list of events as part of Biotech Week Boston, visit here.

As with all Informa events, Informa Markets Engineering's BIOMEDevice event will be run according to official government and local authority guidance in the first instance, as well as any venue or location-specific regulations. In addition, all Informa events worldwide, irrespective of format or location, will follow onsite safety measures called Informa AllSecure. These guidelines will help to ensure participants maximize their time while feeling confident and safe.

Stay connected across the BIOMEDevice Boston event #BIOMEDevice